With Aus/NZ success found by RMY’s product/market fit and now making initial processes more efficient, it will enable the USA SAAS deployment ready to scale to the next stage of growth then overall profitability.
I think you are being a tad harsh on cash outflows which employee costs form the majority of.
Look at what’s occurring globally with wage inflation/pressures, bright minds come with a cost input.
Personally I wouldn’t want to loose quality staff for being excessively tight with the purse strings at this stage of development.
An overall reduction of 32% from Q1 in nothing to sneeze at.
Profitability is not far away as DW has stated and end of FY 22 should be the time if not sooner.
We are closer to profitability than ever.
Hasaman![]()
- Forums
- ASX - By Stock
- RMY
- Ann: Quarterly business update and Appendix 4C
RMY
rma global limited
Add to My Watchlist
0.00%
!
2.7¢

Ann: Quarterly business update and Appendix 4C, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.93M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 210571 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 482607 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 32000 | 0.028 |
1 | 176459 | 0.026 |
2 | 310000 | 0.025 |
1 | 40000 | 0.024 |
1 | 200000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 482607 | 2 |
0.033 | 350000 | 1 |
0.035 | 294117 | 1 |
0.036 | 22000 | 1 |
0.040 | 78987 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
RMY (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online